Sfoglia per SSD
Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of irinotecan and temozolomide combination against colon carcinoma
2005-01-01 Tentori, L; Leonetti, C; Scarsella, M; Vergati, M; Muzi, A; Forini, O; Xu, W; Zhang, J; Graziani, G
Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against melanoma growing at the CNS site
2004-01-01 Tentori, L; Leonetti, C; Scarsella, M; Xu, W; Calvin, D; Morgan, L; Tang, Z; Wozniak, K; Alemu, C; Hoover, R; Lapidus, R; Zupi, G; Zhang, J; Graziani, G
Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia
2022-09-01 Micallef, B; Nistico, R; Bjerrum, Ow; Sarac, Sb; Butler, D; Serracino-Inglott, A; Borg, J
Outcomes at 12 months in a population of elderly patients discharged from a Rehabilitation Unit
2008-01-01 Bellelli, G; Magnifico, F; Trabucchi, Mm
Outcomes of a computer-based cognitive rehabilitation program on Alzheimer's disease patients compared with those on patients affected by mild cognitive impairment
2006-01-01 Cipriani, G; Bianchetti, A; Trabucchi, Mm
Outcomes of Nonagenarian Patients After Rehabilitation Following Hip Fracture Surgery
2012-01-01 Torpilliesi, T; Bellelli, G; Morghen, S; Gentile, S; Ricci, E; Turco, R; Trabucchi, Mm
Outcomes of older people admitted to postacute facilities with delirium [12]
2006-01-01 Bellelli, G; Trabucchi, Mm
Overexpression of HTPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells
2008-01-01 Puca, R; Nardinocchi, L; Pistritto, G; D'Orazi, G
Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection
2009-01-01 Amantea, D; Marrone, M; Nistico', Rg; Federici, M; Bagetta, G; Bernardi, G; Mercuri, Nb
p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells
2014-01-01 Henson, S; Lanna, A; Riddell, N; Franzese, O; Macaulay, R; Griffiths, S; Puleston, D; Watson, A; Simon, A; Tooze, S; Akbar, A
Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate
2014-01-03 Federici, M; Latagliata, E; Ledonne, A; Rizzo, F; Feligioni, M; Sulzer, D; Dunn, M; Sames, D; Gu, H; Nistico', Rg; Puglisi Allegra, S; Mercuri, Nb
Paraquat- and rotenone-induced models of Parkinson's disease
2011-01-01 Nistico', Rg; Mehdawy, B; Piccirilli, S; Mercuri, Nb
PARP inhibitors for cancer treatment
2011-01-01 Graziani, G
PARP inhibitors for cancer treatment: an update on current clinical trials.
2011-01-01 Graziani, G; Tentori, L
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets.
2013-11-01 Shah, G; Robu, M; Purohit, N; Rajawat, J; Tentori, L; Graziani, G
PARP-1 inhibition to treat cancer, ischemia, inflammation
2005-01-01 Graziani, G; Battaini, Fm; Zhang, J
PARP-1 inhibitor: a novel approach to enhance efficacy of chemotherapy.
2006-01-01 Tentori, L
PARP-1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy
2010-01-01 Rizzo, A; Salvati, E; Scarsella, M; Porru, M; Iachettini, S; Tentori, L; Graziani, G; D’Incalci, M; Stevens, M; Orlandi, A; Passeri, D; Gilson, E; Zupi, G; Leonetti, C; Biroccio, A
PARP-1 modulates amyloid beta peptide-induced neuronal damage.
2013-09-24 Martire, S; Fuso, A; Rotili, D; Tempera, I; Giordano, C; De Zottis, I; Muzi, A; Vernole, P; Graziani, G; Lococo, E; Faraldi, M; Maras, B; Scarpa, S; Mosca, L; D'Erme, M
PARP-1 signaling of Topoisomerase 1-dependent DNA damage in carcinoma cells.
2010-01-01 D’Onofrio, G; Tramontano, F; Maselli, V; Dorio, A; Muzi, A; Maselli, V; Fulgione, D; Graziani, G; Malanga, M; Quesada, P
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2005 | Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of irinotecan and temozolomide combination against colon carcinoma | Tentori, L; Leonetti, C; Scarsella, M; Vergati, M; Muzi, A; Forini, O; Xu, W; Zhang, J; Graziani, G | Intervento a convegno | |
1-gen-2004 | Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against melanoma growing at the CNS site | Tentori, L; Leonetti, C; Scarsella, M; Xu, W; Calvin, D; Morgan, L; Tang, Z; Wozniak, K; Alemu, C; Hoover, R; Lapidus, R; Zupi, G; Zhang, J; Graziani, G | Intervento a convegno | |
1-set-2022 | Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia | Micallef, B; Nistico, R; Bjerrum, Ow; Sarac, Sb; Butler, D; Serracino-Inglott, A; Borg, J | Articolo su rivista | |
1-gen-2008 | Outcomes at 12 months in a population of elderly patients discharged from a Rehabilitation Unit | Bellelli, G; Magnifico, F; Trabucchi, Mm | Articolo su rivista | |
1-gen-2006 | Outcomes of a computer-based cognitive rehabilitation program on Alzheimer's disease patients compared with those on patients affected by mild cognitive impairment | Cipriani, G; Bianchetti, A; Trabucchi, Mm | Articolo su rivista | |
1-gen-2012 | Outcomes of Nonagenarian Patients After Rehabilitation Following Hip Fracture Surgery | Torpilliesi, T; Bellelli, G; Morghen, S; Gentile, S; Ricci, E; Turco, R; Trabucchi, Mm | Articolo su rivista | |
1-gen-2006 | Outcomes of older people admitted to postacute facilities with delirium [12] | Bellelli, G; Trabucchi, Mm | Articolo su rivista | |
1-gen-2008 | Overexpression of HTPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells | Puca, R; Nardinocchi, L; Pistritto, G; D'Orazi, G | Articolo su rivista | |
1-gen-2009 | Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection | Amantea, D; Marrone, M; Nistico', Rg; Federici, M; Bagetta, G; Bernardi, G; Mercuri, Nb | Articolo su rivista | |
1-gen-2014 | p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8⁺ T cells | Henson, S; Lanna, A; Riddell, N; Franzese, O; Macaulay, R; Griffiths, S; Puleston, D; Watson, A; Simon, A; Tooze, S; Akbar, A | Articolo su rivista | |
3-gen-2014 | Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate | Federici, M; Latagliata, E; Ledonne, A; Rizzo, F; Feligioni, M; Sulzer, D; Dunn, M; Sames, D; Gu, H; Nistico', Rg; Puglisi Allegra, S; Mercuri, Nb | Articolo su rivista | |
1-gen-2011 | Paraquat- and rotenone-induced models of Parkinson's disease | Nistico', Rg; Mehdawy, B; Piccirilli, S; Mercuri, Nb | Articolo su rivista | |
1-gen-2011 | PARP inhibitors for cancer treatment | Graziani, G | Intervento a convegno | |
1-gen-2011 | PARP inhibitors for cancer treatment: an update on current clinical trials. | Graziani, G; Tentori, L | Intervento a convegno | |
1-nov-2013 | PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets. | Shah, G; Robu, M; Purohit, N; Rajawat, J; Tentori, L; Graziani, G | Articolo su rivista | |
1-gen-2005 | PARP-1 inhibition to treat cancer, ischemia, inflammation | Graziani, G; Battaini, Fm; Zhang, J | Articolo su rivista | |
1-gen-2006 | PARP-1 inhibitor: a novel approach to enhance efficacy of chemotherapy. | Tentori, L | Intervento a convegno | |
1-gen-2010 | PARP-1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy | Rizzo, A; Salvati, E; Scarsella, M; Porru, M; Iachettini, S; Tentori, L; Graziani, G; D’Incalci, M; Stevens, M; Orlandi, A; Passeri, D; Gilson, E; Zupi, G; Leonetti, C; Biroccio, A | Intervento a convegno | |
24-set-2013 | PARP-1 modulates amyloid beta peptide-induced neuronal damage. | Martire, S; Fuso, A; Rotili, D; Tempera, I; Giordano, C; De Zottis, I; Muzi, A; Vernole, P; Graziani, G; Lococo, E; Faraldi, M; Maras, B; Scarpa, S; Mosca, L; D'Erme, M | Articolo su rivista | |
1-gen-2010 | PARP-1 signaling of Topoisomerase 1-dependent DNA damage in carcinoma cells. | D’Onofrio, G; Tramontano, F; Maselli, V; Dorio, A; Muzi, A; Maselli, V; Fulgione, D; Graziani, G; Malanga, M; Quesada, P | Intervento a convegno |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile